Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $141.93 in the prior trading day, Repligen Corp. (NASDAQ: RGEN) closed at $139.99, down -1.37%. In other words, the price has decreased by -$1.37 from its previous closing price. On the day, 0.69 million shares were traded. RGEN stock price reached its highest trading level at $142.98 during the session, while it also had its lowest trading level at $139.82.
Ratios:
Our goal is to gain a better understanding of RGEN by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.69 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 65.75. For the most recent quarter (mrq), Quick Ratio is recorded 5.56 and its Current Ratio is at 6.65. In the meantime, Its Debt-to-Equity ratio is 0.37 whereas as Long-Term Debt/Eq ratio is at 0.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Overweight rating and assigned the stock a target price of $180.
On June 26, 2024, Deutsche Bank Upgraded its rating to Buy which previously was Hold and also lowered its target price recommendation from $180 to $155.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 10 ’24 when Hunt Anthony sold 22,191 shares for $145.37 per share. The transaction valued at 3,225,927 led to the insider holds 139,840 shares of the business.
Hunt Anthony bought 22,191 shares of RGEN for $3,211,481 on Sep 10 ’24. On Aug 02 ’24, another insider, KURIYEL RALF, who serves as the Senior VP, R&D of the company, sold 7,148 shares for $159.35 each. As a result, the insider received 1,139,016 and left with 12,288 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 7840350208 and an Enterprise Value of 7774056448. For the stock, the TTM Price-to-Sale (P/S) ratio is 13.02 while its Price-to-Book (P/B) ratio in mrq is 3.94. Its current Enterprise Value per Revenue stands at 12.906 whereas that against EBITDA is 98.487.
Stock Price History:
Over the past 52 weeks, RGEN has reached a high of $211.13, while it has fallen to a 52-week low of $110.45. The 50-Day Moving Average of the stock is -3.08%, while the 200-Day Moving Average is calculated to be -15.27%.
Shares Statistics:
The stock has traded on average 931.57K shares per day over the past 3-months and 1110250 shares per day over the last 10 days, according to various share statistics. A total of 55.77M shares are outstanding, with a floating share count of 52.09M. Insiders hold about 7.01% of the company’s shares, while institutions hold 103.61% stake in the company. Shares short for RGEN as of 1724976000 were 4049292 with a Short Ratio of 4.35, compared to 1722384000 on 4392198. Therefore, it implies a Short% of Shares Outstanding of 4049292 and a Short% of Float of 8.450000000000001.
